← Leaderboards
Joshua M Shulman
Brigham And Women'S Hospital
$14,788,000
Attributed
$33,550,242
Total exposure
12
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $6.5M · FY2009–25$10M$7.5M$5M$2.5M$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$33,550,242 · 12
By mechanism
U01$16,878,687 · 2
R01$11,368,622 · 5
RF1$3,770,183 · 2
R21$874,625 · 2
K08$658,125 · 1
Top collaborators
- Nicholas Thomas Seyfried19 shared
- Juan Botas12 shared
- Allan I Levey9 shared
- Hugo J Bellen6 shared
- Zhandong Liu6 shared
- Aleksandar Milosavljevic5 shared
- Andrew Lim3 shared
- Paul J Shaw3 shared
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Elizabeth P Henske$25,563,270
- Mel B Feany$26,965,920
Others in their field
Top investigators on “Alzheimer&Apos”
- Jose A Luchsinger · Columbia University Health Sciences$56,595,040
- Eric M Reiman · Banner Health$48,982,487
- Yadong Huang · J. David Gladstone Institutes$40,311,515
- Lindsay A. Farrer · Boston University Medical Campus$34,189,802
- David M Holtzman · Washington University$28,985,806
- Michael W Weiner · Northern California Institute Res &Educ$28,197,224
Research focus
Alzheimer&AposDrosophila GenusS DiseaseBrainTau ProteinsInnovationGeneticAutopsyAffectGenesValidationIn VivoPathologyInvestigationAgingAdultNeurodegenerative DisordersSamplingNerve DegenerationPathway InteractionsBaseDissectionCohortLink
Grant awards (46)
Functional Genomic Dissection of Alzheimer's Disease in Humans and Drosophila Models$1,557,889
U01 · FY2025 · AG · contact PI
Bidirectional interactions between sleep and Alzheimer's disease: Functional dissection of the brain transcriptome in humans and Drosophila$675,211
R01 · FY2025 · AG
Network Medicine for Alzheimers Disease: Functional Dissection and Pharmacologic Perturbation of a Human Brain Synaptic Regulatory Expression Signature$499,303
R01 · FY2025 · AG · contact PI
Functional Genomic Dissection of Alzheimer's Disease in Humans and Drosophila Models$1,589,683
U01 · FY2024 · AG · contact PI
Bidirectional interactions between sleep and Alzheimer's disease: Functional dissection of the brain transcriptome in humans and Drosophila$691,438
R01 · FY2024 · AG
Functional Genomic Dissection of Alzheimer's Disease in Humans and Drosophila Models$401,250
U01 · FY2024 · AG · contact PI
Functional Genomic Dissection of Alzheimer's Disease in Humans and Drosophila Models$1,594,999
U01 · FY2023 · AG · contact PI
Functional Genomic Dissection of Alzheimer's Disease in Humans and Drosophila Models$1,603,971
U01 · FY2022 · AG · contact PI
AMP-AD Brain Proteomic Network Enhancement, Validation, and Translation into CSF Biomarkers$1,561,246
U01 · FY2022 · AG
Network Medicine for Alzheimers Disease: Functional Dissection and Pharmacologic Perturbation of a Human Brain Synaptic Regulatory Expression Signature$1,509,105
RF1 · FY2022 · AG · contact PI
AMP-AD Brain Proteomic Network Enhancement, Validation, and Translation into CSF Biomarkers$391,250
U01 · FY2022 · AG
Bidirectional interactions between sleep and Alzheimer's disease: Functional dissection of the brain transcriptome in humans and Drosophila$2,261,078
RF1 · FY2021 · AG
Functional Genomic Dissection of Alzheimer's Disease in Humans and Drosophila Models$1,629,020
U01 · FY2021 · AG · contact PI
AMP-AD Brain Proteomic Network Enhancement, Validation, and Translation into CSF Biomarkers$1,413,975
U01 · FY2021 · AG
Functional Dissection of Alzheimer's Disease Networks in Drosophila: from Association to Causal Modulators of Age-Dependent Neurodegeration$858,120
R01 · FY2021 · AG
Metabolo-Genetic Dissection of GBA and Lysosomal Genes in Parkinson's Disease and Lewy Body Dementia$200,000
R21 · FY2021 · AG · contact PI
Functional Dissection of Alzheimer's Disease Networks in Drosophila: from Association to Causal Modulators of Age-Dependent Neurodegeration$136,666
R01 · FY2021 · AG
AMP-AD Brain Proteomic Network Enhancement, Validation, and Translation into CSF Biomarkers$13,600
U01 · FY2021 · AG
AMP-AD Brain Proteomic Network Enhancement, Validation, and Translation into CSF Biomarkers$1,861,246
U01 · FY2020 · AG
Functional Dissection of Alzheimer's Disease Networks in Drosophila: from Association to Causal Modulators of Age-Dependent Neurodegeration$719,765
R01 · FY2020 · AG
Tau-Spliceosome Interactions in Alzheimer's Disease$641,161
R01 · FY2020 · AG · contact PI
Functional Validation of the CD2AP Susceptibility Network in Alzheimer's Disease$542,653
R01 · FY2020 · AG · contact PI
AMP-AD Brain Proteomic Network Enhancement, Validation, and Translation into CSF Biomarkers$271,410
U01 · FY2020 · AG
Metabolo-Genetic Dissection of GBA and Lysosomal Genes in Parkinson's Disease and Lewy Body Dementia$240,000
R21 · FY2020 · AG · contact PI
AMP-AD Brain Proteomic Network Enhancement, Validation, and Translation into CSF Biomarkers$40,799
U01 · FY2020 · AG
AMP-AD Brain Proteomic Network Enhancement, Validation, and Translation into CSF Biomarkers$1,456,658
U01 · FY2019 · AG
Functional Dissection of Alzheimer's Disease Networks in Drosophila: from Association to Causal Modulators of Age-Dependent Neurodegeration$733,953
R01 · FY2019 · AG
Tau-Spliceosome Interactions in Alzheimer's Disease$640,069
R01 · FY2019 · AG · contact PI
Functional Validation of the CD2AP Susceptibility Network in Alzheimer's Disease$542,653
R01 · FY2019 · AG · contact PI
AMP-AD Brain Proteomic Network Enhancement, Validation, and Translation into CSF Biomarkers$1,491,691
U01 · FY2018 · AG
Functional Dissection of Alzheimer's Disease Networks in Drosophila: from Association to Causal Modulators of Age-Dependent Neurodegeration$665,200
R01 · FY2018 · AG
Tau-Spliceosome Interactions in Alzheimer's Disease$625,891
R01 · FY2018 · AG · contact PI
Functional Validation of the CD2AP Susceptibility Network in Alzheimer's Disease$495,578
R01 · FY2018 · AG · contact PI
Functional Dissection of Alzheimer's Disease Networks in Drosophila: from Association to Causal Modulators of Age-Dependent Neurodegeration$679,825
R01 · FY2017 · AG
Tau-Spliceosome Interactions in Alzheimer's Disease$629,707
R01 · FY2017 · AG · contact PI
Functional Validation of the CD2AP Susceptibility Network in Alzheimer's Disease$514,409
R01 · FY2017 · AG · contact PI
Tau-Spliceosome Interactions in Alzheimer's Disease$648,994
R01 · FY2016 · AG · contact PI
Functional Validation of the CD2AP Susceptibility Network in Alzheimer's Disease$428,026
R01 · FY2016 · AG · contact PI
Functional Validation of Parkinsons Disease Susceptibility Genes in Drosophila$237,750
R21 · FY2015 · NS · contact PI
Functional Validation of Parkinsons Disease Susceptibility Genes in Drosophila$196,875
R21 · FY2014 · NS · contact PI
Exploring the Genetics of Alzheimer's Disease in Humans and Drosophila$131,625
K08 · FY2013 · AG · contact PI
Exploring the Genetics of Alzheimer's Disease in Humans and Drosophila$123,525
K08 · FY2012 · AG · contact PI
Exploring the Genetics of Alzheimer's Disease in Humans and Drosophila$8,100
K08 · FY2012 · AG · contact PI
Exploring the Genetics of Alzheimer's Disease in Humans and Drosophila$131,625
K08 · FY2011 · AG · contact PI
Exploring the Genetics of Alzheimer's Disease in Humans and Drosophila$131,625
K08 · FY2010 · AG · contact PI
Exploring the Genetics of Alzheimer's Disease in Humans and Drosophila$131,625
K08 · FY2009 · AG · contact PI